Catalyst Wire Dossier Catalyst Wire Dossier

MS CONTIN

Morphine sulfate · Rhodes Pharmaceuticals L.P.
Drug timelines are a Plus or Pro feature.

20 regulatory and trial events tracked for MS CONTIN, covering 2007-05-11 to 2025-12-22. Get the full timeline:

Most recent: FDA Approved: MS CONTIN — Supplemental Application (Rhodes Pharmaceuticals L.P.)

See pricing